Mirum Pharmaceuticals, Inc. financial data

Symbol
MIRM on Nasdaq
Location
Foster City, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 04 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 320% % -12%
Quick Ratio 16% % -20%
Debt-to-equity 185% % 4.1%
Return On Equity -16% % 61%
Return On Assets -6% % 62%
Operating Margin -9% % 72%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51,393,574 shares 7.1%
Common Stock, Shares, Outstanding 51,314,176 shares 7%
Entity Public Float $1,500,000,000 USD 81%
Common Stock, Value, Issued $5,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 50,639,231 shares 6%
Weighted Average Number of Shares Outstanding, Diluted 56,993,841 shares 19%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $471,794,000 USD 54%
Operating Income (Loss) $41,791,000 USD 56%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $40,830,000 USD 58%
Income Tax Expense (Benefit) $593,000 USD -68%
Net Income (Loss) Attributable to Parent $41,423,000 USD 58%
Earnings Per Share, Basic 0 USD/shares 59%
Earnings Per Share, Diluted 0 USD/shares 58%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $282,021,000 USD 26%
Accounts Receivable, after Allowance for Credit Loss, Current $107,132,000 USD 56%
Inventory, Net $24,021,000 USD 11%
Assets, Current $530,575,000 USD 37%
Property, Plant and Equipment, Net $1,277,000 USD 5.4%
Operating Lease, Right-of-Use Asset $8,500,000 USD -7%
Intangible Assets, Net (Excluding Goodwill) $231,895,000 USD -9.3%
Other Assets, Noncurrent $9,918,000 USD 84%
Assets $785,115,000 USD 18%
Accounts Payable, Current $12,167,000 USD 27%
Employee-related Liabilities, Current $36,981,000 USD 60%
Accrued Liabilities, Current $110,224,000 USD 40%
Liabilities, Current $160,359,000 USD 39%
Operating Lease, Liability, Noncurrent $7,361,000 USD -13%
Other Liabilities, Noncurrent $15,981,000 USD 302%
Liabilities $493,069,000 USD 13%
Accumulated Other Comprehensive Income (Loss), Net of Tax $37,000 USD -96%
Retained Earnings (Accumulated Deficit) $661,814,000 USD -6.7%
Stockholders' Equity Attributable to Parent $292,046,000 USD 26%
Liabilities and Equity $785,115,000 USD 18%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,961,000 USD -113%
Net Cash Provided by (Used in) Financing Activities $6,359,000 USD 428%
Net Cash Provided by (Used in) Investing Activities $16,134,000 USD
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 51,314,176 shares 7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $10,681,000 USD -165%
Deferred Tax Assets, Valuation Allowance $167,392,000 USD 17%
Deferred Tax Assets, Gross $169,360,000 USD 18%
Operating Lease, Liability $9,396,000 USD -5.9%
Payments to Acquire Property, Plant, and Equipment $41,000 USD 215%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $42,306,000 USD 57%
Lessee, Operating Lease, Liability, to be Paid $10,840,000 USD -9.3%
Operating Lease, Liability, Current $2,035,000 USD 35%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,733,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,668,000 USD 12%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,444,000 USD -27%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,734,000 USD 9.1%
Deferred Tax Assets, Operating Loss Carryforwards $38,404,000 USD -5.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $12,965,000 USD 24%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,948,000 USD -22%
Operating Lease, Payments $583,000 USD 102%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $23,900,000 USD 6.7%
Depreciation, Depletion and Amortization $6,052,000 USD 6.8%
Share-based Payment Arrangement, Expense $65,649,000 USD 46%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%